These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17583757)

  • 1. Squalestatin protects neurons and reduces the activation of cytoplasmic phospholipase A2 by Abeta(1-42).
    Bate C; Williams A
    Neuropharmacology; 2007 Aug; 53(2):222-31. PubMed ID: 17583757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glimepiride protects neurons against amyloid-β-induced synapse damage.
    Osborne C; West E; Nolan W; McHale-Owen H; Williams A; Bate C
    Neuropharmacology; 2016 Feb; 101():225-36. PubMed ID: 26432105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethanol protects cultured neurons against amyloid-β and α-synuclein-induced synapse damage.
    Bate C; Williams A
    Neuropharmacology; 2011 Dec; 61(8):1406-12. PubMed ID: 21903110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docosahexaenoic and eicosapentaenoic acids increase neuronal death in response to HuPrP82-146 and Abeta 1-42.
    Bate C; Marshall V; Colombo L; Diomede L; Salmona M; Williams A
    Neuropharmacology; 2008 May; 54(6):934-43. PubMed ID: 18355880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Squalestatin alters the intracellular trafficking of a neurotoxic prion peptide.
    Wilson R; Bate C; Boshuizen R; Williams A; Brewer J
    BMC Neurosci; 2007 Nov; 8():99. PubMed ID: 18034899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-β(1-40) inhibits amyloid-β(1-42) induced activation of cytoplasmic phospholipase A2 and synapse degeneration.
    Bate C; Williams A
    J Alzheimers Dis; 2010; 21(3):985-93. PubMed ID: 20634578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vitro model for synaptic loss in neurodegenerative diseases suggests a neuroprotective role for valproic acid via inhibition of cPLA2 dependent signalling.
    Williams RS; Bate C
    Neuropharmacology; 2016 Feb; 101():566-75. PubMed ID: 26116815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Squalestatin cures prion-infected neurons and protects against prion neurotoxicity.
    Bate C; Salmona M; Diomede L; Williams A
    J Biol Chem; 2004 Apr; 279(15):14983-90. PubMed ID: 14754889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of statins in an in vitro model of Alzheimer's disease.
    Fonseca AC; Proença T; Resende R; Oliveira CR; Pereira CM
    J Alzheimers Dis; 2009; 17(3):503-17. PubMed ID: 19363255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol ester hydrolase inhibitors reduce the production of synaptotoxic amyloid-β oligomers.
    McHale-Owen H; Bate C
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):649-659. PubMed ID: 29247837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coenzyme Q10 protects against amyloid beta-induced neuronal cell death by inhibiting oxidative stress and activating the P13K pathway.
    Choi H; Park HH; Koh SH; Choi NY; Yu HJ; Park J; Lee YJ; Lee KY
    Neurotoxicology; 2012 Jan; 33(1):85-90. PubMed ID: 22186599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monomeric amyloid-β reduced amyloid-β oligomer-induced synapse damage in neuronal cultures.
    Bate C; Williams A
    Neurobiol Dis; 2018 Mar; 111():48-58. PubMed ID: 29272738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid-β peptide fibrils induce nitro-oxidative stress in neuronal cells.
    Ill-Raga G; Ramos-Fernández E; Guix FX; Tajes M; Bosch-Morató M; Palomer E; Godoy J; Belmar S; Cerpa W; Simpkins JW; Inestrosa And NC; Muñoz FJ
    J Alzheimers Dis; 2010; 22(2):641-52. PubMed ID: 20858976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid beta(1-42) and its beta(25-35) fragment induce activation and membrane translocation of cytosolic phospholipase A2 in bovine retina capillary pericytes.
    Anfuso CD; Assero G; Lupo G; Nicotra A; Cannavò G; Strosznajder RP; Rapisarda P; Pluta R; Alberghina M
    Biochim Biophys Acta; 2004 Nov; 1686(1-2):125-38. PubMed ID: 15522829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid-β-induced synapse damage is mediated via cross-linkage of cellular prion proteins.
    Bate C; Williams A
    J Biol Chem; 2011 Nov; 286(44):37955-37963. PubMed ID: 21900234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bindarit, inhibitor of CCL2 synthesis, protects neurons against amyloid-β-induced toxicity.
    Severini C; Passeri PP; Ciotti M; Florenzano F; Possenti R; Zona C; Di Matteo A; Guglielmotti A; Calissano P; Pachter J; Mercanti D
    J Alzheimers Dis; 2014; 38(2):281-93. PubMed ID: 23948942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol synthesis inhibitors protect against platelet-activating factor-induced neuronal damage.
    Bate C; Rumbold L; Williams A
    J Neuroinflammation; 2007 Jan; 4():5. PubMed ID: 17233902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-Synuclein-induced synapse damage in cultured neurons is mediated by cholesterol-sensitive activation of cytoplasmic phospholipase A2.
    Bate C; Williams A
    Biomolecules; 2015 Mar; 5(1):178-93. PubMed ID: 25761116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic stimulation of GABAA receptor with muscimol reduces amyloid beta protein (25-35)-induced neurotoxicity in cultured rat cortical cells.
    Lee BY; Ban JY; Seong YH
    Neurosci Res; 2005 Aug; 52(4):347-56. PubMed ID: 15896866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. {beta}-Amyloid-induced neurodegeneration and protection by structurally diverse microtubule-stabilizing agents.
    Michaelis ML; Ansar S; Chen Y; Reiff ER; Seyb KI; Himes RH; Audus KL; Georg GI
    J Pharmacol Exp Ther; 2005 Feb; 312(2):659-68. PubMed ID: 15375176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.